Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP119690.RAV8iYCd5Y6z3KwJlGSFjqZVAAi6eI3CzZQ8sw81up83w130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119690.RAV8iYCd5Y6z3KwJlGSFjqZVAAi6eI3CzZQ8sw81up83w130_provenance.
• NP125217.RAcPDliZxGDlRGDcN_UOtEN_nT2NzuWUOInU180L6RaWY130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP125217.RAcPDliZxGDlRGDcN_UOtEN_nT2NzuWUOInU180L6RaWY130_provenance.
• NP126514.RAeYhTzxRZrw2A_4M_ifUr27G98yxAU0vn3zA5dpqNMEU130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126514.RAeYhTzxRZrw2A_4M_ifUr27G98yxAU0vn3zA5dpqNMEU130_provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP157951.RAXo-KV0nnxzr9TJLOUDxkYcjJ64AKewFlnRMHFkOrz48130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157951.RAXo-KV0nnxzr9TJLOUDxkYcjJ64AKewFlnRMHFkOrz48130_provenance.
• NP157954.RAYjY2SxgAUljYKel6_ZP4hihbLoC4f2kzogQlqnC06ug130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157954.RAYjY2SxgAUljYKel6_ZP4hihbLoC4f2kzogQlqnC06ug130_provenance.
• NP157956.RAaU5yTvDzx_z02i2iJ8HBh3hYwE7R6SHOSxwqqm8CczE130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157956.RAaU5yTvDzx_z02i2iJ8HBh3hYwE7R6SHOSxwqqm8CczE130_provenance.
• NP157958.RAa1iQeVmxpLqItR1vSHO1Iyis9rvDiLei0V7hK4SooLs130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157958.RAa1iQeVmxpLqItR1vSHO1Iyis9rvDiLei0V7hK4SooLs130_provenance.
• NP64950.RAlCJjbRAcw_aVlxtHNslu7c9CWV9DIenetttUf1s7W5I130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64950.RAlCJjbRAcw_aVlxtHNslu7c9CWV9DIenetttUf1s7W5I130_provenance.
• NP64963.RAuB3lEKjYYiBhitHmySDfM6rCLJunjVEMvERiRi6j-Fc130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64963.RAuB3lEKjYYiBhitHmySDfM6rCLJunjVEMvERiRi6j-Fc130_provenance.
• NP76090.RAr8EXv23alJKJu6_cGSRF67REFsdssW1ngsGbY1u7aFo130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76090.RAr8EXv23alJKJu6_cGSRF67REFsdssW1ngsGbY1u7aFo130_provenance.
• NP87111.RAiOqyKrlPRBFSVvGn0QD_z9MF6omwY27JuQ5L9e0crQU130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87111.RAiOqyKrlPRBFSVvGn0QD_z9MF6omwY27JuQ5L9e0crQU130_provenance.
• NP119682.RAvNPy6zcKYlS3PIxc9Kl0LN89WVw4puUPhJcVEslPU1E130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119682.RAvNPy6zcKYlS3PIxc9Kl0LN89WVw4puUPhJcVEslPU1E130_provenance.
• NP125201.RAmZCJZ8L0CZLsca6cRRx_LfL2G4X0S6oO3IrOngoRo9I130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP125201.RAmZCJZ8L0CZLsca6cRRx_LfL2G4X0S6oO3IrOngoRo9I130_provenance.
• NP125207.RAib1CvnO-cK2ooMvljEc0_wTiVnRJa2QjGgaCSdG01U8130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP125207.RAib1CvnO-cK2ooMvljEc0_wTiVnRJa2QjGgaCSdG01U8130_provenance.
• NP125257.RAhRfIKedm73lzRe_CjV3b0QuvlFS7deNW1Bz75vnmL1M130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP125257.RAhRfIKedm73lzRe_CjV3b0QuvlFS7deNW1Bz75vnmL1M130_provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP157957.RADPa6LfhyDvKuJnNVkpp80SbK1oXxs1U2ke-OWSPTapc130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157957.RADPa6LfhyDvKuJnNVkpp80SbK1oXxs1U2ke-OWSPTapc130_provenance.
• NP157945.RAuMZTTdPyIkekqOfBUF-TiLjehRIKFrVpMBPPf9_qVlM130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157945.RAuMZTTdPyIkekqOfBUF-TiLjehRIKFrVpMBPPf9_qVlM130_provenance.
• NP157947.RArhYk2wfoypXNRZyTCFeQdHhm2w0RbQ8OG_5CM3Yvv-k130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157947.RArhYk2wfoypXNRZyTCFeQdHhm2w0RbQ8OG_5CM3Yvv-k130_provenance.
• NP157949.RAgn_MGfBBMM-5a6js3QXkM72AXatPCwl3utx0pDfDKak130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157949.RAgn_MGfBBMM-5a6js3QXkM72AXatPCwl3utx0pDfDKak130_provenance.
• NP157953.RAiHrCA358bZPb6S3d5DaYgA-LYoe0YZrRZBPFE0NXlBI130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157953.RAiHrCA358bZPb6S3d5DaYgA-LYoe0YZrRZBPFE0NXlBI130_provenance.
• NP157955.RAorIvFe8kHew95vSon2XjqtVX60L8fM41QJtusyBE86s130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157955.RAorIvFe8kHew95vSon2XjqtVX60L8fM41QJtusyBE86s130_provenance.
• NP65294.RAGPBS94241PTKfTc6kjRxhv46O_m7WD4vbq2wuNW3CZM130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP65294.RAGPBS94241PTKfTc6kjRxhv46O_m7WD4vbq2wuNW3CZM130_provenance.
• NP119704.RAx_VSfRN6_1xC4gvyzt68GBWzuQYI0RVN1t67gDvRswM130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119704.RAx_VSfRN6_1xC4gvyzt68GBWzuQYI0RVN1t67gDvRswM130_provenance.
• NP125262.RA59M_830YSDjKQf9zDSqqvRzyy7eRe0EjO0BDd7UuMRg130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP125262.RA59M_830YSDjKQf9zDSqqvRzyy7eRe0EjO0BDd7UuMRg130_provenance.
• NP126508.RAM2kkciVgq8jkPBOTBrLhZVl36mSrOn4d0yLehuGWW0Q130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126508.RAM2kkciVgq8jkPBOTBrLhZVl36mSrOn4d0yLehuGWW0Q130_provenance.
• NP126527.RALfETjycezuFSOiHMvRq54sYW7wx6qkXgDK3Oexr4ZGo130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126527.RALfETjycezuFSOiHMvRq54sYW7wx6qkXgDK3Oexr4ZGo130_provenance.
• NP157943.RAOVCHH9fIpj7ITDS8qMgW8gPEutq5SAzbWg-Gruy6Woc130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157943.RAOVCHH9fIpj7ITDS8qMgW8gPEutq5SAzbWg-Gruy6Woc130_provenance.
• NP157948.RAEwaQ4wx9mlxbHP7amIJOFl1d0Vsu7O4LPFr1_BfOO8A130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157948.RAEwaQ4wx9mlxbHP7amIJOFl1d0Vsu7O4LPFr1_BfOO8A130_provenance.
• NP157950.RAJ_SVaQd6zssN0wHveJ8Vb83fZqaYPkM8sTMWkNkXRqo130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157950.RAJ_SVaQd6zssN0wHveJ8Vb83fZqaYPkM8sTMWkNkXRqo130_provenance.
• NP157952.RAMAPGk5oUbphD7AFJ9-7nHpQ-j5AT_ziL_R4r6wFkxIk130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157952.RAMAPGk5oUbphD7AFJ9-7nHpQ-j5AT_ziL_R4r6wFkxIk130_provenance.
• NP157944.RA7t9AOET51kLiyMXyy9JxFHMuXQ4WQvEeSXUWBc8tBxE130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157944.RA7t9AOET51kLiyMXyy9JxFHMuXQ4WQvEeSXUWBc8tBxE130_provenance.
• NP157946.RAz5vsNc7UlD6N6e0WrWKPOB6az3z1KEUotvO8d-MF-Bo130_assertion description "[Clinical parameters can predict for mutation carriers and help prioritize gene testing to reduce costs in nonsyndromic pheochromocytoma presentations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157946.RAz5vsNc7UlD6N6e0WrWKPOB6az3z1KEUotvO8d-MF-Bo130_provenance.